- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04143763
Mobile Message Intervention for Stroke Caregivers' Psychological Support
The Effect of an Ecological Momentary Intervention for Stroke Caregivers' Psychological Support: a Pilot Feasibility Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
75% of stroke caregivers report severe caregiver burdens, with 60% of stroke caregivers reporting at least one depressive symptom in Hong Kong. However, caregivers can experience difficulties in accessing and fully utilising existing services due to the varying types of care needs and its intensities amongst stroke survivors.
Ecological momentary intervention (EMI) as an innovative and personalised intervention has shown great potential in supporting psychological well-being; yet, there are no studies on using EMI for the caregivers' psychological support. The proposed trial aims to reduce stroke caregivers' psychological distress by delivering EMI through instant messaging applications to provide personalised and real-time support led by healthcare professionals.
Stroke caregivers screened by Patient Health Questionnaire-9 (PHQ-9) with scores ranging from 5 to 19 will be recruited from multiple sites including community centres, rehabilitation centres and outpatient clinics in public hospitals in Hong Kong, and individually randomised into the intervention group (n=20) or control group (n=20). The intervention group will receive the personalised instant messages for 4 weeks. The control group will receive general health information and regular messages reminding them to participate in follow-up surveys. The primary outcome will be the score of PHQ-9 at 4 weeks. Secondary outcomes will include anxiety, perceived stress, and caregiver burden.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jung Jae LEE, PhD
- Phone Number: 85239176971
- Email: leejay@hku.hk
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- Hong Kong PHAB Association
-
Contact:
- ADMIN ADMIN
- Phone Number: 26511468
- Email: jcfc@hkphab.org.hk
-
Hong Kong, Hong Kong
- Recruiting
- Hong Kong Stroke Association
-
Contact:
- Admin Admin
- Phone Number: 23078257
- Email: hk_stroke_a@yahoo.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Primary family caregiver of stroke survivor
- Able to read and communicate in Chinese
- Able to use mobile phone text messaging function
- PHQ-9 ranged from 5 to 19
Exclusion Criteria:
- Professional medical personnel and care assistants
- Has provided care for <1 month prior to recruitment
- Has diagnosis of psychiatric disease or is currently taking psychotropic drug
- PHQ-9 ≥ 20 (i.e., severe depressive symptom)
- Currently participating in any type of psychological support intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Intervention group
receive mobile messages supporting caregivers' psychological well-being, according to the participants' preferences in intervention group.
|
Using the messaging function of mobile devices, EMI offers a framework to deliver health information to the target population, corresponding to each individual's demands in terms of type (e.g., photo, text and/or voice message), timing, duration, and frequency of the messages, which are different to the features from other interventions
|
No Intervention: Control group
receive general health information through a mobile message.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change depressive symptoms by Patient Health Questionnaire (PHQ-9) Scale (questionnaire) at 4 weeks
Time Frame: 4 weeks
|
Patient Health Questionnaire (PHQ-9) Scale: PHQ-9 is a scale for screening depression in primary care.
It consists of 9 items with 4 likert scale.
Score range is from 0 to 27 (higher score = higher severity of depressive symptom).
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change anxiety symptoms by Generalized Anxiety Disorder-7 (GAD-7) Scale at 4 weeks
Time Frame: 4 weeks
|
Generalized Anxiety Disorder-7 (GAD-7) Scale: GAD-7 is a scale for screening anxiety in primary care. It consists of 7 items with 4 likert scale. Score range is from 0 to 21 (higher score = higher severity of anxiety symptom). |
4 weeks
|
Change stress levels by Perceived Stress Scale (PSS-4) at 4 weeks
Time Frame: 4 weeks
|
Perceived Stress Scale (PSS-4); PSS-4 is a scale for screening stress level.
It consists of 4 items with 5 likert scale.
Score range is from 0 to 16 (higher score = higher severity of stress).
|
4 weeks
|
Change caring burdens by Burden Interview-4 (ZBI-4) at 4 weeks
Time Frame: 4 weeks
|
Burden Interview-4 (ZBI-4) Scale: ZBI-4 is a scale for screening carer's burdens. It consists of 4 items with 5 likert scale. Score range is from 0 to 16 (higher score = higher severity of caring burden). |
4 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HKUSON_LEE1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Ecological Momentary Intervention (EMI)
-
Chestnut Health SystemsNational Institute on Drug Abuse (NIDA)CompletedRecovery | Substance Use Disorder (SUD)United States
-
Trustees of Dartmouth CollegeNational Institute on Drug Abuse (NIDA)CompletedCigarette SmokingUnited States
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Rutgers UniversityRecruiting
-
Harvard UniversityNational Institute of Mental Health (NIMH); Massachusetts General HospitalUnknownSuicide, Attempted | Suicide and Self-harmUnited States
-
The New SchoolUniversity of ZurichActive, not recruitingSelf EfficacyUnited States
-
Rutgers, The State University of New JerseyMassachusetts General HospitalRecruitingSuicidal Ideation | Distress, EmotionalUnited States
-
Johns Hopkins UniversityRakai Health Sciences ProgramCompletedEcological Momentary Assessment and Intervention
-
Harvard UniversityMassachusetts General Hospital; American Psychological FoundationUnknownSuicidal Ideation | Suicide, Attempted | Hopeless
-
Heidelberg UniversityRecruitingHealthy | Depressive Disorder, Major | Persistent Depressive DisorderGermany
-
University of Illinois at ChicagoNational Institute on Aging (NIA)CompletedCognitive Impairment | Sedentary BehaviorUnited States